Sanofi's VaxRabneo receives EU approval for rabies prevention
智通财经2026/09/18 10:51Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Sanofi (SNY.US)'s VaxRabneo has received approval from EU regulators for rabies prevention.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CoreWeave completes pricing for $3.7 billion convertible senior notes issuance
智通财经•2026/09/18 11:21
Dillard's will transfer its listing to the Texas Stock Exchange
智通财经•2026/09/18 11:11
Bank of Montreal raises Phillips 66 price target to $310
智通财经•2026/09/18 11:11
